IRCT201011295270N1
Completed
Phase 1
Treatment of macular edema secondary to central vein occlusion
Banco de Olhos de Sorocaba0 sites15 target enrollmentTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- central vein occlusion.
- Sponsor
- Banco de Olhos de Sorocaba
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion crieria: Visual acuity equal or worse than 20/40 and equal or greater than 20/400; Minimum OCT central thickness of 250 microns
- •Onset of central vein occlusion between three and 12 months.
- •Visual acuity better than 20/40 on the other eye
- •Exclusion criteria: neovascularization of the retina, optic disk, iris or angle.
- •Uncontrolled glaucoma
- •Intraocular surgery and/or injection of any medication in the past 3 months
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Treatment of macular edema secondary to central or branch vein occlusion by dexamethazone intravitreal injection - Ozurdex in post-occlusive macular edemamacular edema seconday to central or branch retinal vein occlusionMedDRA version: 13.1Level: SOCClassification code 10015919Term: Eye disordersSystem Organ Class: 10015919 - Eye disordersEUCTR2011-000425-72-ITIRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS
Active, not recruiting
Phase 1
Treatment of macular edema due to central retinal vein occlusion with ranibizumab (Lucentis®). - Lucentis in CRVOThis case-series is designed to evaluate the safety and efficacy of intravitreal ranibizumab (Lucentis®) in the treatment of macular edema due to central retinal vein occlusion.MedDRA version: 12.1Level: LLTClassification code 10007972Term: Central retinal vein occlusionMedDRA version: 12.1Level: LLTClassification code 10054467Term: Macular edemaEUCTR2009-017782-30-ATMedizinische Universität Graz, Universitäts-Augenklinik
Completed
Not Applicable
Treatment of macular edema secondary to branch retinal vein occlusion with sub-tenon triamcinolone acetonide injectioMacular edema following BRVOJPRN-UMIN000031215Aichi Medicak University Department of Ophthalmology60
Recruiting
Phase 2
Intraretinal vessel treatment for central retinal vein occlusioCetntral Retinal Artery and Vein OcclusionJPRN-UMIN000007958Intraretinal vessel treatment for central retinal vein occlusion study team10
Recruiting
Not Applicable
Intravitreal anti-VEGF therapies for macular edema folowing age-related macular degeneratioage-related macular degenerationJPRN-UMIN000023676Kawasaki Medical School500